Completed
Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia
NCT01121042
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective and Schizophreniform Disorders, +2 more
- Locations
-
- Monash Alfred Psychiatry Research Centre (MAPrc) Melbourne, Victoria, Australia